Randomized Phase II Trial of Adjuvant WT-1 Analog Peptide Vaccine in Patients with Malignant Pleural Mesothelioma after Completion of Multimodality Therapy

2013 ◽  
Author(s):  
Lee M. Krug
Keyword(s):  
Phase Ii ◽  
Malignant Pleural Mesothelioma ◽  
Phase Ii Trial ◽  
Peptide Vaccine ◽  
Multimodality Therapy ◽  
Pleural Mesothelioma ◽  
Randomized Phase Ii ◽  
Analog Peptide

scholarly journals P3.04-006 SYSTEMS-2: Randomized Phase II Trial of Standard Versus Dose Escalated Radiotherapy for Pain in Malignant Pleural Mesothelioma

2017 ◽  
Vol 12 (11) ◽  
pp. S2287
Author(s):  
M. Ashton ◽  
N. O'Rourke ◽  
N. Macleod ◽  
S. Smith ◽  
R. Valentine ◽  
...  
Keyword(s):  
Phase Ii ◽  
Malignant Pleural Mesothelioma ◽  
Phase Ii Trial ◽  
Pleural Mesothelioma ◽  
Randomized Phase Ii

221 A randomized phase II trial of pegylated arginine deaminase (ADI-PEG 20) in patients with malignant pleural mesothelioma

Lung Cancer ◽  
2006 ◽  
Vol 54 ◽  
pp. S54 ◽  
Author(s):  
P.W. Szlosarek ◽  
D.A. Fennell ◽  
R.M. Rudd ◽  
M. Lind ◽  
M. Ranson ◽  
...  
Keyword(s):  
Phase Ii ◽  
Malignant Pleural Mesothelioma ◽  
Phase Ii Trial ◽  
Pleural Mesothelioma ◽  
Randomized Phase Ii

Randomized, double-blinded, phase II trial of a WT1 peptide vaccine as adjuvant therapy in patients with malignant pleural mesothelioma (MPM).

2011 ◽  
Vol 29 (15_suppl) ◽  
pp. TPS139-TPS139 ◽  
Author(s):  
L. M. Krug ◽  
A. S. Tsao ◽  
S. Kass ◽  
V. W. Rusch ◽  
W. D. Travis ◽  
...  
Keyword(s):  
Adjuvant Therapy ◽  
Phase Ii ◽  
Malignant Pleural Mesothelioma ◽  
Phase Ii Trial ◽  
Peptide Vaccine ◽  
Pleural Mesothelioma ◽  
Double Blinded

Randomized phase II study of adjuvant WT1 vaccine (SLS-001) for malignant pleural mesothelioma (MPM) after multimodality therapy.

2016 ◽  
Vol 34 (15_suppl) ◽  
pp. 8519-8519 ◽  
Author(s):  
Marjorie Glass Zauderer ◽  
Tao Dao ◽  
Valerie W. Rusch ◽  
Michelle S. Ginsberg ◽  
Anne S. Tsao ◽  
...  
Keyword(s):  
Phase Ii ◽  
Malignant Pleural Mesothelioma ◽  
Phase Ii Study ◽  
Multimodality Therapy ◽  
Pleural Mesothelioma ◽  
Randomized Phase Ii

Questions Regarding the Randomized Phase II Trial of Defactinib as Maintenance Therapy in Malignant Pleural Mesothelioma

2019 ◽  
Vol 37 (25) ◽  
pp. 2293-2294 ◽  
Author(s):  
Ken Masuda ◽  
Hiroto Ishiki ◽  
Shunsuke Oyamada ◽  
Masaki Shimizu ◽  
Daisuke Kiuchi ◽  
...  
Keyword(s):  
Maintenance Therapy ◽  
Phase Ii ◽  
Malignant Pleural Mesothelioma ◽  
Phase Ii Trial ◽  
Pleural Mesothelioma ◽  
Randomized Phase Ii

Randomized phase II trial of pemetrexed/cisplatin with or without CBP501 in patients with advanced malignant pleural mesothelioma

Lung Cancer ◽  
2014 ◽  
Vol 85 (3) ◽  
pp. 429-434 ◽  
Author(s):  
L.M. Krug ◽  
A.J. Wozniak ◽  
H.L. Kindler ◽  
R. Feld ◽  
M. Koczywas ◽  
...  
Keyword(s):  
Phase Ii ◽  
Malignant Pleural Mesothelioma ◽  
Phase Ii Trial ◽  
Pleural Mesothelioma ◽  
Randomized Phase Ii
Sign in / Sign up

Export Citation Format

Share Document